Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C35H53N3O9 |
Molecular Weight | 659.81 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCNC(=O)[C@@H](NC(=O)[C@@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C)CC2=C(OC)C(OC)=C(OC)C=C2)C(C)C
InChI
InChIKey=BEUUJDAEPJZWHM-COROXYKFSA-N
InChI=1S/C35H53N3O9/c1-22(2)29(33(41)36-17-18-43-6)38-32(40)25(20-24-15-16-28(44-7)31(46-9)30(24)45-8)21-27(39)26(19-23-13-11-10-12-14-23)37-34(42)47-35(3,4)5/h10-16,22,25-27,29,39H,17-21H2,1-9H3,(H,36,41)(H,37,42)(H,38,40)/t25-,26+,27+,29+/m1/s1
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis of potent and orally active HIV-protease inhibitors. | 1996 Jun |
|
Profile of CGP 61755: a novel and potent HIV-1 protease inhibitor that shows enhanced anti-HIV activity when combined with other antiretroviral agents in vitro. | 1996 Oct 26 |
|
In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitors. | 1997 May |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8916294
Lasinavir (CGP 61755) is highly specific for HIV-1 protease with an IC50 of 1 nM. The ED90 in MT-2, PBLs and macrophages is infected with laboratory strains of HIV-1 or clinical isolates is 30-100 nM. In chronically infected macrophages the ED90 is 1000 nM. When the antiviral activity of CGP 61755 on HIV-1 infected lymphocytes was examined using serum free medium an ED99 of 60 nM was determined, while in the presence of 10% human serum the same activity was achieved with 120 nM.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C97366
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082558
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
175385-62-3
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
SUB08407MIG
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
464372
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
DTXSID801045798
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
Lasinavir
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
C80627
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
0QGV8237I3
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104331
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY | |||
|
7565
Created by
admin on Fri Dec 15 16:39:20 GMT 2023 , Edited by admin on Fri Dec 15 16:39:20 GMT 2023
|
PRIMARY |
ACTIVE MOIETY